Warren Lowman

ORCID: 0000-0002-6981-389X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • Antibiotics Pharmacokinetics and Efficacy
  • Antimicrobial Resistance in Staphylococcus
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Infection Control in Healthcare
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pneumonia and Respiratory Infections
  • Liver Disease and Transplantation
  • Clostridium difficile and Clostridium perfringens research
  • Organ Transplantation Techniques and Outcomes
  • Urinary Tract Infections Management
  • Airway Management and Intubation Techniques
  • Renal Transplantation Outcomes and Treatments
  • Medical Device Sterilization and Disinfection
  • Nail Diseases and Treatments
  • Nosocomial Infections in ICU
  • Microscopic Colitis
  • Cystic Fibrosis Research Advances
  • Tracheal and airway disorders
  • Sepsis Diagnosis and Treatment
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Vibrio bacteria research studies

University of the Witwatersrand
2015-2024

Wits University Donald Gordon Medical Centre
2015-2024

Right to Care
2018-2023

National Health Laboratory Service
2008-2018

Lancet Laboratories
2018

Biology of Infection
2018

Engineering Associates (United States)
2018

Tel Aviv Sourasky Medical Center
2017

Tel Aviv University
2017

Israel Ministry of Health
2017

Belén Gutiérrez‐Gutiérrez Elena Salamanca Marina de Cueto Po‐Ren Hsueh Pierluigi Viale and 84 more José Ramón Paño‐Pardo Mario Venditti Mario Tumbarello George L. Daikos Rafael Cantón Yohei Doi Felipe Francisco Tuon Ilias Karaiskos Elena Pérez‐Nadales Mitchell J. Schwaber Özlem Kurt Azap Maria Souli Emmanuel Roilides Spyros Pournaras Murat Akova Federico Pérez Joaquín Bermejo Antonio Oliver Manel Almela Warren Lowman Benito Almirante Robert A. Bonomo Yehuda Carmeli David L. Paterson Álvaro Pascual Jesús Rodríguez‐Baño María Dolores del Toro Juan Gálvez-Acebal Marco Falcone Alessandro Russo Helen Giamarellou Enrico Maria Trecarichi Angela Raffaella Losito Elisa García‐Vázquez Alicia Hernández Juana Carretero Gómez Germán Bou Εlias Iosifidis Núria Prim Ferrán Navarro Beatriz Mirelis Anna Skiada Julia Origüen Rafael San Juan Mario Fernández‐Ruiz Nieves Larrosa Mireia Puig‐Asensio José Miguel Cisneros José Molina V. González V. Rucci E. Ruiz de Gopegui C. Marinescu Luis Martı́nez-Martı́nez M.C. Fariñas M.E. Cano Mónica Gozalo Marta Mora-Rillo Carolina Navarro-San Francisco Carmen Peña Sílvia Gómez-Zorrilla Fé Tubau Athanassios Tsakris Olympia Zarkotou Anastasia Antoniadou Garyphallia Poulakou Johann Pitout Divya Virmani Julián Torre-Cisneros Julia Guzmán-Puche Özant Helvacı Ahmet Şahin Vicente Pintado Pablo Ramos-Ruiz Michele Bartoletti Maddalena Giannella E. Tacconelli F Riemenschneider Esther Calbo Cristina Badía Mariona Xercavins Oriol Gasch D. Fontanals E. Jové

10.1016/s1473-3099(17)30228-1 article EN The Lancet Infectious Diseases 2017-04-22

The spread of extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is leading to increased carbapenem consumption. Alternatives carbapenems need be investigated. We investigated whether β-lactam/β-lactamase inhibitor (BLBLI) combinations are as effective in the treatment bloodstream infections (BSI) due ESBL-E. A multinational, retrospective cohort study was performed. Patients with monomicrobial BSI ESBL-E were studied; specific criteria applied for inclusion patients...

10.1128/aac.00365-16 article EN Antimicrobial Agents and Chemotherapy 2016-05-03

Abstract Candida auris is an invasive healthcare-associated fungal pathogen. Cases of candidemia, defined as illness in patients with cultured from blood, were detected through national laboratory-based surveillance South Africa during 2016–2017. We identified viable isolates by using mass spectrometry and sequencing. Among 6,669 cases (5,876 species identification) 269 hospitals, 794 (14%) caused C. auris. The incidence risk for all candidemia at 133 hospitals was 83.8 (95% CI 81.2–86.4)...

10.3201/eid2509.190040 article EN cc-by Emerging infectious diseases 2019-09-01

10.1016/j.mayocp.2016.06.024 article EN Mayo Clinic Proceedings 2016-10-01

To determine the epidemiology of Candida auris in South Africa, we reviewed data from public- and private-sector diagnostic laboratories that reported confirmed probable cases invasive disease colonization for October 2012-November 2016. We defined a case as first isolation C. any specimen person age admitted to healthcare facility Africa. where laboratory had used nonconfirmatory biochemical identification method haemulonii was cultured. analyzed 1,692 cases; 93% were facilities, 92% known...

10.3201/eid2411.180368 article EN cc-by Emerging infectious diseases 2018-11-01

Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was define and validate a predictive risk score 30 day mortality.A multinational retrospective cohort study including consecutive episodes of BSI ESBL-E performed; cases were randomly assigned derivation (DC) or validation (VC). main variable all-cause mortality. A developed using logistic regression coefficients the...

10.1093/jac/dkw513 article EN Journal of Antimicrobial Chemotherapy 2016-12-14
Massimo Sartelli Francesco M. Labricciosa Pamela Barbadoro Léonardo Pagani Luca Ansaloni and 95 more Adrian Brink Jean Carlet Ashish K. Khanna Alain Chichom‐Mefire Federico Coccolini Salomone Di Saverio Addison K. May Pierluigi Viale Richard R. Watkins Luigia Scudeller Lilian M. Abbo Fikri M. Abu‐Zidan A. R. K. Adesunkanmi Sara Al-Dahir Majdi N. Al‐Hasan Halil Alış Carlos Alves André R. Araujo da Silva Goran Augustin Miklosh Bala Philip S. Barie Marcelo A. Beltrán Aneel Bhangu Bouchra Belefquih Stephen M. Brecher Miguel Caínzos Adrián Camacho-Ortíz Marco Catani Sujith J Chandy Asri Che Jusoh Jill R. Cherry‐Bukowiec Osvaldo Chiara Elif Çolak Oliver A. Cornely Yunfeng Cui Zaza Demetrashvili Belinda De Simone Jan J. De Waele Sameer Dhingra Francesco Di Marzo Agron Dogjani Gereltuya Dorj Laurent Dortet Therèse M. Duane Mutasim M. Elmangory Mushira Enani Paula Ferrada Esteban Foíanini Mahir Gachabayov Chinmay Gandhi Wagih Ghnnam Helen Giamarellou Georgios Gkiokas Harumi Gomi Tatjana Goranović Ewen A. Griffiths Rosio Isabel Guerra Gronerth Julio C. Haidamus Monteiro Timothy Craig Hardcastle Andreas Hecker Adrien Montcho Hodonou Orestis Ioannidis Arda Işık Katia Iskandar Hossein Samadi Kafil Souha S. Kanj Lewis J. Kaplan Garima Kapoor Aleksandar Karamarković Jakub Kenig Ivan Kerschaever Faryal Khamis Vladimir Khokha Ronald Kiguba Hong Bin Kim Wen‐Chien Ko Kaoru Koike I. M. Kozlovskа Anand Kumar Leonel Lagunes Rifat Latifi Jae Gil Lee Young R. Lee Ari Leppäniemi Yousheng Li Stephen Y. Liang Warren Lowman Gustavo M. Machaín Marc Maegele Piotr Major Sydney Malama Ramiro Manzano-Núñez Athanasios Marinis Isidro Martínez Casas Sanjay Marwah

Antimicrobial Stewardship Programs (ASPs) have been promoted to optimize antimicrobial usage and patient outcomes, reduce the emergence of antimicrobial-resistant organisms. However, best strategies for an ASP are not definitively established likely vary based on local culture, policy, routine clinical practice, probably limited resources in middle-income countries. The aim this study is evaluate structures stewardship teams (ASTs) surgical departments from different regions world.A...

10.1186/s13017-017-0145-2 article EN cc-by World Journal of Emergency Surgery 2017-08-01

OBJECTIVE To compare the epidemiology, clinical characteristics, and mortality of patients with bloodstream infections (BSI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (ESBL-EC) versus ESBL-producing Klebsiella pneumoniae (ESBL-KP) to examine differences in characteristics outcome between BSIs isolates CTX-M other ESBL genotypes METHODS As part INCREMENT project, 33 tertiary hospitals 12 countries retrospectively collected data on adult diagnosed ESBL-EC BSI or...

10.1017/ice.2018.63 article EN Infection Control and Hospital Epidemiology 2018-04-05

Introduction We aimed to obtain an in-depth understanding on recent antimicrobial resistance trends and molecular epidemiology of S. aureus bacteraemia (SAB). Methods Thirteen academic centres in South Africa were included from June 2010 until July 2012. susceptibility testing was performed the MicroScan Walkaway. Real-time PCR using LightCycler 480 II done for mecA nuc. SCCmec spa-typing finalized with conventional PCR. selected one isolate per common spa type province multilocus sequence...

10.1371/journal.pone.0145429 article EN cc-by PLoS ONE 2015-12-31

There is little information about the efficacy of active alternative drugs to carbapenems except β-lactam/β-lactamase inhibitors for treatment bloodstream infections (BSIs) due extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-E). The objective this study was assess outcomes patients with BSI ESBL-E who received empiric therapy such (other [OADs]) or carbapenems. A multinational retrospective cohort OADs performed. Cox regression including a propensity score receiving...

10.1093/cid/cix606 article EN Clinical Infectious Diseases 2017-07-13

We aimed to compare the efficacy of ceftazidime-avibactam (CAZ-AVI) versus best available therapy (BAT) in solid organ transplant (SOT) recipients with bloodstream infection caused by carbapenemase-producing Klebsiella pneumoniae (CPKP-BSI). A retrospective (2016-2021) observational cohort study was performed 14 INCREMENT-SOT centers (ClinicalTrials.gov identifier: NCT02852902; Impact Specific Antimicrobials and MIC Values on Outcome Bloodstream Infections Due ESBL- or...

10.1016/j.ajt.2023.03.011 article EN cc-by-nc-nd American Journal of Transplantation 2023-04-05

Data about the efficacy of ertapenem for treatment bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are limited. We compared clinical and other carbapenems in monomicrobial BSI ESBL-E. A multinational retrospective cohort study (INCREMENT project) was performed (ClinicalTrials.gov identifier: NCT01764490). Patients given monotherapy with or were compared. Empirical targeted therapies analysed. Propensity scores used control confounding; sensitivity analyses...

10.1093/jac/dkv502 article EN Journal of Antimicrobial Chemotherapy 2016-02-22

Background. The increasing rates of antimicrobial resistance observed in the nosocomial pathogen Klebsiella pneumoniae are major public health concern worldwide. Objectives. To describe antibiotic susceptibility profiles K. isolates from bacteraemic patients submitted by sentinel laboratories five regions South Africa mid-2010 to mid-2012. Molecular methods were used detect most commonly found extended-spectrum beta-lactamase (ESBL) and carbapenemase genes. Methods. Thirteen academic centres...

10.7196/samj.7617 article EN South African Medical Journal 2014-06-19

Nocardiosis is an underrecognized clinical entity in South Africa, for which interspecies epidemiological and differences are poorly understood. The taxonomical state of flux the lack a simple antimicrobial susceptibility testing method partly responsible. Definitive identification molecularly based, further complicates study this ubiquitous organism, as methodology beyond scope most routine diagnostic laboratories. Etest has been proposed alternative to reference broth microdilution method,...

10.1128/jcm.01073-10 article EN Journal of Clinical Microbiology 2010-10-28
Rudzani Mashau Susan Meiring Vanessa Quan Jeremy Nel Greg Greene and 95 more Andrea Arnaiz García Colin Menezes Denasha L. Reddy Michelle Venter Sarah Stacey Matamela Madua Lia Boretti Thomas S. Harrison Graeme Meintjes Amir Shroufi Laura Triviño-Duran John Black Nelesh P. Govender Shareef Abrahams Vanessa Pearce Masego Moncho Jeanette Wadula Motlatji Reratilwe Bonnie Maloba A A Hoosen Charl Verwey Colin Menezes David Moore Dina Pombo Gary Reubenson Grace Ntlemo Lauren Richards Maphoshane Nchabeleng Merika Tsitsi Moamokgethi Moshe Mohammed Y. Said Molebogeng Kolojane Lesego Mothibi Nicolette du Plessis Rispah Chomba Teena Thomas Theunis Avenant Trusha Nana Vindana Chibabhai Adhil Maharj Douglas Wilson Fathima Naby Halima Dawood Khine Swe Swe-Han Lisha Sookan Nomonde Dlamini Praksha Ramajathan Prasha Mahabeer Prathna Bhola Romola Naidoo Sumayya Haffejee Surendra Sirkar Yeishna Ramkillawan Ken Hamese Ngoaka Sibiya Phetho Mangena Ruth Lekalakala Greta Hoyland Sindi Ntuli Ebrahim Variava Ignatius Khantsi Omphile Mekgoe Adrian Brink Elizabeth Prentice Kessendri Reddy Andrew Whitelaw Ebrahim Hoosien Inge Zietsman Terry Marshall Xoliswa Poswa Chetna Govind J.A.H. Smit Keshree Pillay Sharona Seetharam Victoria Howell Catherine Samuel Marthinus Senekal Colleen Bamford Andries Dreyer Louis Marcus Warren Lowman Anne von Gottberg Anthony M. Smith Azwifarwi Mathunjwa Cecilia d'Abreu Cecilia Miller Cheryl Cohen Farzana Ismail Harry Moultrie Husna Ismail Jacqueline Weyer Jackie Kleynhans Jennifer Rossouw John Frean Joy Ebonwu Judith Mwansa-Kambafwile

10.1016/s1473-3099(22)00234-1 article EN The Lancet Infectious Diseases 2022-06-21

Hospital-acquired infections (HAIs) are a significant although unquantified burden in South Africa. Lack of adequate surveillance compounds this problem.To report on the establishment and outcomes unit-specific system for hospital-acquired infections, based international standards, private academic hospital.Active device-associated (DAIs) was introduced over 2-year period. The US National Healthcare Safety Network (NHSN) utilising standardised definitions. Analysis DAI rates device...

10.7196/samj.2016.v106i5.10783 article EN cc-by-nc South African Medical Journal 2016-04-07

Echinocandins are recommended as first-line agents to treat invasive infections caused by Candida glabrata since this organism is inherently less susceptible azoles. However, resistance echinocandins has been described in C. due amino acid changes the hotspot regions of FKS1 and FKS2 genes. In report, we describe first two South African isolates with echinocandin mediated mutations gene. Both were cultured from urine specimens private-sector patients.

10.1016/j.mmcr.2016.03.004 article EN cc-by-nc-nd Medical Mycology Case Reports 2016-03-01

Acinetobacter baumannii is an opportunistic pathogen and causes various infections in patients. This study aimed to describe the clinical, epidemiological molecular characteristics of A. isolated from BCs patients at a tertiary-level hospital South Africa. Ninety-six isolates bloodstream were collected. Clinical recorded patient files. Organism identification AST was performed using automated systems. PCR screening for mcr-1 mcr-5 genes done. To infer genetic relatedness, dendrogram...

10.3389/fmicb.2022.863129 article EN cc-by Frontiers in Microbiology 2022-08-05

Acinetobacter baumannii is a prolific nosocomial pathogen renowned for its multidrug-resistant nature. We report case of community-acquired meningitis due to A. baumannii. The highlights the potential pathogenicity this organism and raises concerns that highly adaptable may soon evolve into significant community pathogen, too.

10.1099/jmm.0.47781-0 article EN Journal of Medical Microbiology 2008-04-24

Background and objectives. Hospital-acquired infections (HAIs) are largely preventable through risk analysis modification of practice. Anaesthetic practice plays a limited role in the prevention HAIs, although laryngoscope use decontamination is an area concern. We aimed to assess level microbial contamination re-usable blades at public hospital South Africa. Setting. The theatre complex secondary-level Johannesburg. Methods. Blades from two different theatres were sampled twice daily, using...

10.7196/samj.6385 article EN cc-by-nc South African Medical Journal 2013-02-19
Coming Soon ...